Overview

Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets

Status:
Completed

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the proportion of patients alive after 12 months of the beginning of the trial in patients with advanced pancreatic carcinoma individually selected and grouped according to the expression in tumor tissue for therapeutic targets.

Phase:

Phase 2

Details

Lead Sponsor:

Centro Nacional de Investigaciones Oncologicas CARLOS III

Collaborators:

Apices Soluciones S.L.
Grupo Hospital de Madrid
Hospital Universitario de Fuenlabrada

Treatments:

Capecitabine
Erlotinib Hydrochloride
Fluorouracil
Folfirinox
Gemcitabine
Leucovorin
Oxaliplatin